glp-1 positive side effects Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 and GIP in Type
Description
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study

From a precision-endocrinology perspective, GLP-1RAs could serve dual aims in patients who harbor both metabolic dysfunction (obesity/insulin resistance/MASLD) and thyroid autoimmunity-attenuating inflammatory tone while improving weight, glycemia, and hepatic steatosis [7,50,54]

[DOI] [PMC free article] [PubMed] [Google Scholar] 69.Davies M., Faerch L., Jeppesen O.K., Pakseresht A., Pedersen S.D., Perreault L., Rosenstock J., Shimomura I., Viljoen A., Wadden T.A., et al

Most professional organizations only recommend it
If burping persists beyond 12 weeks, discuss dose adjustments with your PlexusDx provider

The table shows that SGLT2is and aldosterone antagonists provide the most robust and additive reductions in albuminuria and CKD progression, with SGLT2is showing consistent benefit across all albuminuria and eGFR levels [122]
